Tilray Brands (TLRY) Change in Account Payables (2017 - 2020)
Tilray Brands (TLRY) posted Change in Account Payables of -$15.2 million for Q1 2020, up 18.92% on a QoQ basis from -$18.8 million in Q4 2019, and down 1399.31% year-over-year from $1.2 million in Q2 2019.
Tilray Brands (TLRY) Change in Account Payables (2017 - 2020) Analysis & Trends
Tilray Brands' Change in Account Payables history runs 4 years deep, the most recent figure standing at -$15.2 million for Q1 2020.
- Quarterly Change in Account Payables fell 1399.31% year-over-year to -$15.2 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $3.9 million (up 499.09% YoY) and the FY2020 annual result came in at -$20.5 million, down 202.41% from the prior year.
- Change in Account Payables was -$15.2 million for Q1 2020 at Tilray Brands, up from -$18.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $38.9 million in Q3 2019 and bottomed at -$18.8 million in Q4 2019.
- A 4-year average of $1.3 million and a median of $147500.0 in 2017 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 1206.37% in 2019, while the deepest fall reached 2714.21% in 2019.
- Tilray Brands' Change in Account Payables stood at $4.6 million in 2017, then sank by 84.25% to $718000.0 in 2018, then plunged by 2714.21% to -$18.8 million in 2019, then grew by 18.92% to -$15.2 million in 2020.
- Business Quant data shows TLRY's Change in Account Payables at -$15.2 million in Q1 2020, -$18.8 million in Q4 2019, and $38.9 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -15.22 Mn |
| Mar 31, 2020 | -15.22 Mn |
| Dec 31, 2019 | -18.77 Mn |
| Dec 31, 2019 | -18.77 Mn |
| Sep 30, 2019 | 38.93 Mn |
| Sep 30, 2019 | 38.93 Mn |
| Mar 31, 2019 | -1.02 Mn |
| Mar 31, 2019 | -1.02 Mn |
| Dec 31, 2018 | 718,000.00 |
| Dec 31, 2018 | 718,000.00 |
| Sep 30, 2018 | -3.52 Mn |
| Sep 30, 2018 | -3.52 Mn |
| Jun 30, 2018 | 4.47 Mn |
| Jun 30, 2018 | 4.47 Mn |
| Mar 31, 2018 | 3.55 Mn |
| Mar 31, 2018 | 3.55 Mn |
| Dec 31, 2017 | 4.56 Mn |
| Dec 31, 2017 | 4.56 Mn |
| Sep 30, 2017 | -423,000.00 |
| Sep 30, 2017 | -423,000.00 |